ES2121817T3 - Inhibidor de la agregacion plaquetaria inducida por el colageno. - Google Patents

Inhibidor de la agregacion plaquetaria inducida por el colageno.

Info

Publication number
ES2121817T3
ES2121817T3 ES92250245T ES92250245T ES2121817T3 ES 2121817 T3 ES2121817 T3 ES 2121817T3 ES 92250245 T ES92250245 T ES 92250245T ES 92250245 T ES92250245 T ES 92250245T ES 2121817 T3 ES2121817 T3 ES 2121817T3
Authority
ES
Spain
Prior art keywords
collagen
platelet aggregation
inhibitor
aggregation induced
induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92250245T
Other languages
English (en)
Spanish (es)
Inventor
Christiane Noeske-Jungblut
Bernhard Haendler
Jorn Kratzschmar
Wolf-Dieter Schleuning
Alejandro Alagon
Lourival Possani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2121817T3 publication Critical patent/ES2121817T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES92250245T 1991-09-05 1992-09-04 Inhibidor de la agregacion plaquetaria inducida por el colageno. Expired - Lifetime ES2121817T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75621191A 1991-09-05 1991-09-05
US81488491A 1991-12-31 1991-12-31
US91438392A 1992-07-17 1992-07-17

Publications (1)

Publication Number Publication Date
ES2121817T3 true ES2121817T3 (es) 1998-12-16

Family

ID=27419489

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92250245T Expired - Lifetime ES2121817T3 (es) 1991-09-05 1992-09-04 Inhibidor de la agregacion plaquetaria inducida por el colageno.

Country Status (16)

Country Link
EP (1) EP0530937B1 (de)
JP (2) JPH07506959A (de)
KR (1) KR100232683B1 (de)
AT (1) ATE169674T1 (de)
AU (1) AU672584B2 (de)
CA (1) CA2117174A1 (de)
DE (1) DE69226580T2 (de)
DK (1) DK0530937T3 (de)
ES (1) ES2121817T3 (de)
FI (1) FI112801B (de)
HU (1) HU218830B (de)
IL (4) IL103065A (de)
NO (1) NO314848B1 (de)
NZ (1) NZ244246A (de)
RU (1) RU2128705C1 (de)
WO (1) WO1993005150A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2186110C2 (ru) * 1994-09-12 2002-07-27 Шеринг Аг Рекомбинантный белок asp-паллидипин, способ его производства и очистки, вектор, штамм, фармацевтическая композиция
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
JP3837519B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のＴｉ−３蛋白質
JP3837518B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のＴｉ−４蛋白質
AU2003227721A1 (en) * 2003-05-02 2004-11-23 Paion Gmbh Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
ATE384735T1 (de) * 2003-05-21 2008-02-15 Ares Trading Sa Verfahren zur chromatographischen analyse einer proteinlösung
EP1760092A1 (de) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. System für Screening von Zellen mit hoher Expression von einem interessierenden Protein
WO2007038749A2 (en) 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
JP5332178B2 (ja) * 2007-11-02 2013-11-06 東洋紡株式会社 多色ルシフェラーゼの検出方法
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
CN109125355B (zh) * 2018-08-03 2022-07-08 昆明医科大学第一附属医院 心脉隆抗血小板及抗血栓药理应用
CN110327994B (zh) * 2019-07-11 2020-12-08 北京理工大学 一种多维微流控电泳芯片及检测装置，检测方法

Also Published As

Publication number Publication date
HU218830B (hu) 2000-12-28
NO314848B1 (no) 2003-06-02
DE69226580T2 (de) 1999-03-04
KR100232683B1 (ko) 1999-12-01
NO940771D0 (no) 1994-03-04
HUT70271A (en) 1995-09-28
DK0530937T3 (da) 1999-05-10
IL103065A0 (en) 1993-02-21
AU672584B2 (en) 1996-10-10
WO1993005150A1 (en) 1993-03-18
EP0530937B1 (de) 1998-08-12
RU2128705C1 (ru) 1999-04-10
RU94045930A (ru) 1996-07-20
IL119491A0 (en) 1997-01-10
DE69226580D1 (de) 1998-09-17
JP2003313199A (ja) 2003-11-06
ATE169674T1 (de) 1998-08-15
NZ244246A (en) 1994-03-25
IL103065A (en) 2001-11-25
IL119491A (en) 2000-11-21
HU9400662D0 (en) 1994-06-28
AU2502292A (en) 1993-04-05
FI112801B (fi) 2004-01-15
NO940771L (no) 1994-03-04
FI941052A0 (fi) 1994-03-04
CA2117174A1 (en) 1993-03-18
EP0530937A1 (de) 1993-03-10
FI941052A (fi) 1994-03-04
IL119492A0 (en) 1997-01-10
JPH07506959A (ja) 1995-08-03

Similar Documents

Publication Publication Date Title
ATE155143T1 (de) 2-substituierte indan-2-mercaptoacetylamid- verbindungen mit enkephalinase und ace- hemmwirkung
ATE143972T1 (de) 2-substituierte indane-2-carboxyalkyl- verbindungen mit enkephalinase und ace- hemmwirkung
ES2121817T3 (es) Inhibidor de la agregacion plaquetaria inducida por el colageno.
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
DE3780045D1 (de) Verwendung von basischen anorganischen magnesium- oder calciumsalzen zur stabilisierung von benzimidazolderivaten.
ES2193901T1 (es) Derivados de prostaglandina para el tratamiento de glaucoma o hipertension ocular.
ITPD910047A0 (it) Strumento per la legatura di emorroidi o simili
DE59101613D1 (de) Knochennagel zur Versorgung von Oberarmfrakturen.
DK249389A (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
ES2191659T3 (es) Derivados heterociclicos substituidos utiles como inhibidores de la agregacion plaquetaria.
DE59200277D1 (de) Substituierte Diaminophthalimide und Analoga.
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
ES2063796T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.
ES2066927T3 (es) Procedimiento para la purificacion de polialquileneterglicoles, que contienen heteropoliacidos.
AR240482A1 (es) Procedimiento para el curtimiento economico al cromo.
ES2038642T3 (es) Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
ITRM910146U1 (it) Strumento chirurgico per l'introduzione di protesi peniene.
DE59203472D1 (de) Verwendung von dl-valin, dessen estern und/oder salzen zur bekämpfung von kopfschuppen.
ATE155686T1 (de) Hemmung von metastasen bei krebspatienten mit pyridyloxazol-2-onen
ES2061667T3 (es) Agente hipotensivo para el tratamiento o prevencion de la hipertension.
ES1008313Y (es) Clavo intramedular para el tratamiento de fracturas de huesos largos.
ES1004491Y (es) Horma para el tratamiento ortopedico de calzado.
DE69211588D1 (de) Verwendung von 1-Phenoxycarbonyl-2-pyrrolidinonderivaten zur Behandlung oder Verhütung der Blutplättchenaggregation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 530937

Country of ref document: ES